Literature DB >> 17022108

High interleukin-6 plasma levels are associated with functional impairment in older patients with vascular dementia.

G Zuliani1, G Guerra, M Ranzini, L Rossi, M R Munari, A Zurlo, A Blè, S Volpato, A R Atti, R Fellin.   

Abstract

In older individuals, inflammatory mechanisms have been linked to the pathogenesis of both dementia and functional impairment. In this cross-sectional study we have investigated the possible association between some markers of systemic inflammation and functional status, in a sample of one hundred and forty older demented patients including 60 patients with late onset Alzheimer's disease (LOAD) and 80 with vascular dementia (VD). Functional status was evaluated by Barthel Index (BI); the total score ranged from 0 (total dependency) to 20 (total autonomy). Interleukin-1beta, Tumor Necrosis Factor-alpha, Interleukin- 6, Interleukin- 8, and Transforming Grow Factor beta were quantified by ELISA. Among the cytokines evaluated, only IL-6 was correlated with the BI (r: -0.32, p < 0.001). The mean levels of IL-6 progressively decreased from I (9.50 pg/mL), to II (6.40 pg/mL), to III BI tertile (4.80 pg/mL) (p < 0.02). At multiple regression analysis, IL-6 was associated with BI in the whole sample and in VD, but not in LOAD, independent of age, gender, smoking, alcohol consumption, hypertension, diabetes, coronary heart disease, previous stroke, and mini mental state examination score. Our study suggests the existence of an independent and negative relationship between IL-6 plasma levels and functional status in older individuals with vascular dementia. This finding might contribute to explain the 'excess of disability' phenomenon described in older demented patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17022108     DOI: 10.1002/gps.1674

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  18 in total

1.  Biomarkers of basic activities of daily living in Alzheimer's disease.

Authors:  James R Hall; Leigh A Johnson; Robert C Barber; Hoa T Vo; A Scott Winter; Sid E O'Bryant
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 2.  Vascular cognitive impairment: disease mechanisms and therapeutic implications.

Authors:  Deborah A Levine; Kenneth M Langa
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

Review 3.  Interleukin 6 and cognitive dysfunction.

Authors:  Isabel Trapero; Omar Cauli
Journal:  Metab Brain Dis       Date:  2014-04-30       Impact factor: 3.584

4.  Low-grade systemic inflammation is associated with functional disability in elderly people affected by dementia.

Authors:  Carlo Cervellati; Alessandro Trentini; Cristina Bosi; Giuseppe Valacchi; Mario Luca Morieri; Amedeo Zurlo; Gloria Brombo; Angelina Passaro; Giovanni Zuliani
Journal:  Geroscience       Date:  2018-02-10       Impact factor: 7.713

5.  Levels of amyloid beta-42, interleukin-6 and tumor necrosis factor-alpha in Alzheimer's disease and vascular dementia.

Authors:  Sema Uslu; Zubeyde Eken Akarkarasu; Demet Ozbabalik; Serhat Ozkan; Omer Colak; Emine Sutken Demirkan; Ayşe Ozkiris; Canan Demirustu; Ozkan Alatas
Journal:  Neurochem Res       Date:  2012-03-22       Impact factor: 3.996

6.  IL-6 regulation of synaptic function in the CNS.

Authors:  Donna L Gruol
Journal:  Neuropharmacology       Date:  2014-11-22       Impact factor: 5.250

Review 7.  Inflammatory mediators as biomarkers in brain disorders.

Authors:  Domenico Nuzzo; Pasquale Picone; Luca Caruana; Sonya Vasto; Annalisa Barera; Calogero Caruso; Marta Di Carlo
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

8.  Correlation between interleukin-6 promoter and C-reactive protein (CRP) polymorphisms and CRP levels with the Mainz Severity Score Index for Fabry disease.

Authors:  G Altarescu; G Chicco; C Whybra; S Delgado-Sanchez; N Sharon; M Beck; D Elstein
Journal:  J Inherit Metab Dis       Date:  2008-01-05       Impact factor: 4.982

9.  Identification of peripheral inflammatory markers between normal control and Alzheimer's disease.

Authors:  Sam-Moon Kim; Juhee Song; Seungwoo Kim; Changsu Han; Moon Ho Park; Youngho Koh; Sangmee Ahn Jo; Young-Youl Kim
Journal:  BMC Neurol       Date:  2011-05-12       Impact factor: 2.474

10.  Neuroinflammation and cerebrovascular disease in old age: a translational medicine perspective.

Authors:  Mario Di Napoli; Imtiaz M Shah
Journal:  J Aging Res       Date:  2011-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.